We are live on ! Find out more

1,565 hedge funds and large institutions have $109B invested in Merck in 2013 Q4 according to their latest regulatory filings, with 187 funds opening new positions, 581 increasing their positions, 627 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 187 | Existing positions closed: 70

46% more call options, than puts

Call options by funds: $1.39B | Put options by funds: $953M

7% more funds holding

Funds holding: 1,4691,565 (+96)

6% more capital invested

Capital invested by funds: $103B → $109B (+$5.89B)

0.21% more ownership

Funds ownership: 77.81%78.01% (+0.21%)

7% less repeat investments, than reductions

Existing positions increased: 581 | Existing positions reduced: 627

3% less funds holding in top 10

Funds holding in top 10: 117113 (-4)

Holders
1,565
Holders Change
+96
Holders Change %
+6.54%
% of All Funds
45.43%
Holding in Top 10
113
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-3.42%
% of All Funds
3.28%
New
187
Increased
581
Reduced
627
Closed
70
Calls
$1.39B
Puts
$953M
Net Calls
+$434M
Net Calls Change
+$103M
Name Holding Trade Value Shares
Change
Change in
Stake
Capital World Investors
1
Capital World Investors
California
$8.46B +$561M +12,263,172 +7%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$7.71B +$457M +9,997,733 +7%
Vanguard Group
3
Vanguard Group
Pennsylvania
$7.18B +$97.8M +2,139,590 +1%
State Street
4
State Street
Massachusetts
$6.61B +$105M +2,287,073 +2%
Franklin Resources
5
Franklin Resources
California
$4.09B -$284M -6,202,810 -7%
BIT
6
BlackRock Institutional Trust
California
$3.86B -$25.3M -553,332 -0.7%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$2.67B -$386M -8,435,595 -13%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$2.66B +$63.1M +1,379,497 +3%
Dodge & Cox
9
Dodge & Cox
California
$2.44B -$64.1M -1,403,377 -3%
Northern Trust
10
Northern Trust
Illinois
$2.21B +$8.48M +185,484 +0.4%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$2.16B -$104M -2,271,575 -5%
BFA
12
BlackRock Fund Advisors
California
$1.89B +$91.5M +2,001,463 +5%
JP Morgan Chase
13
JP Morgan Chase
New York
$1.67B -$79.9M -1,749,014 -5%
Barrow, Hanley, Mewhinney & Strauss
14
Barrow, Hanley, Mewhinney & Strauss
Texas
$1.47B -$10.4M -228,235 -0.7%
Invesco
15
Invesco
Georgia
$1.45B +$80.1M +1,752,037 +6%
Deutsche Bank
16
Deutsche Bank
Germany
$1.27B +$215M +4,713,574 +21%
BG
17
BlackRock Group
United Kingdom
$1.25B -$159M -3,478,267 -12%
Goldman Sachs
18
Goldman Sachs
New York
$1.16B -$62.4M -1,365,304 -5%
Norges Bank
19
Norges Bank
Norway
$1.11B -$92.5M -2,023,033 -8%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$1.11B +$59.5M +1,301,785 +6%
BA
21
BlackRock Advisors
Delaware
$976M -$304M -6,658,878 -25%
Bank of America
22
Bank of America
North Carolina
$904M -$295M -6,444,993 -25%
Ameriprise
23
Ameriprise
Minnesota
$884M +$136M +2,984,442 +19%
TCIM
24
TIAA CREF Investment Management
New York
$801M -$94.3M -2,062,638 -11%
State Farm Mutual Automobile Insurance
25
State Farm Mutual Automobile Insurance
Illinois
$758M -$19.6M -428,528 -3%

MRK Hedge Fund Activity: Q4 2013 in Review

1,565 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q4 2013, worth a combined $109B — up 5.7% from $103B a quarter earlier.

Buyers outnumbered sellers: 187 funds opened new MRK positions and 70 closed out — a net gain of 117 holders — while 581 added to existing stakes and 627 trimmed.

The largest buyer was Capital World Investors, adding an estimated $561M. The largest seller was Fidelity Investments, cutting an estimated $386M.

  • 1,565 institutional investors held Merck (MRK) as of Q4 2013, up from 1,469 in Q3 2013.
  • Funds reported $109B of Merck stock for Q4 2013, up 5.7% quarter-over-quarter.
  • 187 funds opened new Merck positions in Q4 2013 and 70 closed out, a net change of +117 holders.
  • The largest Merck buyer in Q4 2013 was Capital World Investors, an estimated $561M added.
  • The largest Merck seller in Q4 2013 was Fidelity Investments, an estimated $386M sold.

Based on aggregated 13F filings for Q4 2013.